Ciphergen Biosystems, Inc.
James P. Merryweather, PhD, named EVP, pharmaceutical corporate development
Published in Physician Law Weekly, April 6th, 2005
In his new position, Merryweather will manage Ciphergen's relationships with key pharmaceutical clients based on use of Ciphergen's ProteinChip technology and collaborative services provided through Ciphergen's Biomarker Discovery Center laboratory in Malvern, Pennsylvania and manage pharmaceutical biomarker collaborations.
Merryweather has spent over 20 years in the biotechnology industry in senior positions in research and development, program management, and business development....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2005-04-06)
More Articles from Physician Law Weekly
- AIDS Healthcare Foundation
Legal order allows challenge to AIDS drug pricing in South African to go forward - American College of Physician Executives
Survey showing unethical business practices in U.S. healthcare alarms physicians - Awards
Houston, Texas, attorneys named fellows of American Health Lawyers Association - DaVita, Inc.
Dialysis provider announces receipt of DOJ subpoena - Eon Labs, Inc.
Generics company reports increased income, discusses Novartis merger - EpiTan, Ltd.
Australian company receives ethics approval for phase II endpoint study - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
